Tocilizumab reduces cardiac injury after out-of-hospital cardiac arrest primarily in patients without acute revascularization - Results from a randomized trial, The IMICA trial

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Foundation. Main funding source(s): The Danish Heart Foundation (Reference no. 19-R135-A9302-22125) Lundbeck Foundation (Reference no. R186-2015-2132) BACKGROUND: Patients remaining comatose after the initial resuscitation from out-of-hospital cardi...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Eur Heart J Acute Cardiovasc Care
Auteurs principaux: Meyer, M, Wiberg, S, Grand, J, Meyer, ASP, Obling, L, Kjaergaard, J, Hassager, C
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2021
Sujets:
19.5 - Cardiac Arrest
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8264032/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ehjacc/zuab020.177
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires